366 related articles for article (PubMed ID: 28070123)
1. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
Qin XY; Wu HT; Cao C; Loh YP; Cheng Y
Mol Psychiatry; 2017 Sep; 22(9):1306-1312. PubMed ID: 28070123
[TBL] [Abstract][Full Text] [Related]
2. The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis.
Rodrigues-Amorim D; Rivera-Baltanás T; Bessa J; Sousa N; Vallejo-Curto MC; Rodríguez-Jamardo C; de Las Heras ME; Díaz R; Agís-Balboa RC; Olivares JM; Spuch C
J Psychiatr Res; 2018 Nov; 106():43-53. PubMed ID: 30269004
[TBL] [Abstract][Full Text] [Related]
3. Association of Peripheral Blood Levels of Brain-Derived Neurotrophic Factor With Autism Spectrum Disorder in Children: A Systematic Review and Meta-analysis.
Qin XY; Feng JC; Cao C; Wu HT; Loh YP; Cheng Y
JAMA Pediatr; 2016 Nov; 170(11):1079-1086. PubMed ID: 27654278
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood nerve growth factor levels in major psychiatric disorders.
Rao S; Martínez-Cengotitabengoa M; Yao Y; Guo Z; Xu Q; Li S; Zhou X; Zhang F
J Psychiatr Res; 2017 Mar; 86():39-45. PubMed ID: 27898323
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
Green MJ; Matheson SL; Shepherd A; Weickert CS; Carr VJ
Mol Psychiatry; 2011 Sep; 16(9):960-72. PubMed ID: 20733577
[TBL] [Abstract][Full Text] [Related]
7. Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Du Y; Wu HT; Qin XY; Cao C; Liu Y; Cao ZZ; Cheng Y
J Mol Neurosci; 2018 Jul; 65(3):289-300. PubMed ID: 29956088
[TBL] [Abstract][Full Text] [Related]
8. Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial.
Jena M; Ranjan R; Mishra BR; Mishra A; Nath S; Sahu P; Meher BR; Srinivasan A; Maiti R
J Psychiatr Res; 2019 May; 112():1-6. PubMed ID: 30782512
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment.
Ajami A; Hosseini SH; Taghipour M; Khalilian A
Scand J Immunol; 2014 Jul; 80(1):36-42. PubMed ID: 24498860
[TBL] [Abstract][Full Text] [Related]
12. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies.
Berdenis van Berlekom A; Muflihah CH; Snijders GJLJ; MacGillavry HD; Middeldorp J; Hol EM; Kahn RS; de Witte LD
Schizophr Bull; 2020 Feb; 46(2):374-386. PubMed ID: 31192350
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.
Ciszowski K; Gomółka E; Gawlikowski T; Szpak D; Potoczek A; Boba M
Przegl Lek; 2016; 73(8):552-9. PubMed ID: 29677430
[TBL] [Abstract][Full Text] [Related]
14. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
Shi Y; Luan D; Song R; Zhang Z
Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Significance of Serum Levels of Nerve Growth Factor and Brain Derived Neurotrophic Factor in Diabetic Peripheral Neuropathy.
Sun Q; Tang DD; Yin EG; Wei LL; Chen P; Deng SP; Tu LL
Med Sci Monit; 2018 Aug; 24():5943-5950. PubMed ID: 30145601
[TBL] [Abstract][Full Text] [Related]
16. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis.
Liu SH; Shi XJ; Fan FC; Cheng Y
Sci Rep; 2021 Jan; 11(1):15. PubMed ID: 33420109
[TBL] [Abstract][Full Text] [Related]
18. Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia.
Li XS; Wu HT; Yu Y; Chen GY; Qin XY; Zheng GE; Deng W; Cheng Y
Neurosci Lett; 2018 Nov; 686():28-32. PubMed ID: 30172685
[TBL] [Abstract][Full Text] [Related]
19. Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.
Mohammadi A; Rashidi E; Amooeian VG
Psychiatry Res; 2018 Jul; 265():25-38. PubMed ID: 29680514
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.
Angelucci F; Mathé AA; Aloe L
Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
